Equities Research Analysts’ updated eps estimates for Thursday, August 31st:
Acorda Therapeutics (NASDAQ:ACOR) had its buy rating reaffirmed by analysts at Stifel Nicolaus. They currently have a $26.00 target price on the stock, down from their previous target price of $30.00.
Analog Devices (NASDAQ:ADI) had its overweight rating reaffirmed by analysts at Morgan Stanley. They currently have a $96.00 price target on the stock.
AMAG Pharmaceuticals (NASDAQ:AMAG) had its hold rating reiterated by analysts at Deutsche Bank AG. The firm currently has a $24.00 price target on the stock.
Ambarella (NASDAQ:AMBA) had its overweight rating reaffirmed by analysts at Morgan Stanley. They currently have a $65.00 price target on the stock.
Advanced Micro Devices (NASDAQ:AMD) had its equal weight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $6.00 price target on the stock.
Ameriprise Financial Services (NYSE:AMP) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of Ameriprise outperformed the industry in the last year. The price performance has been backed by impressive earnings surprise history. The company surpassed the Zacks Consensus Estimate for earnings in three of the trailing four quarters. Ameriprise remains well positioned to grow through strategic acquisitions, given its strong liquidity position. Notably, in sync with its plans of expanding products and services, the company completed the acquisition of Investment Professionals, Inc. on July 1. Moreover, its efforts toward modifying product and service-offering capacity are expected to further support top-line growth. However, increasing expenses (mostly due to advertising campaign and technology upgrades) and elevated levels of outflows in the Asset Management segment are expected to hurt the company’s financials in the near term.”
TD Ameritrade Holding Corporation (NASDAQ:AMTD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of TD Ameritrade have outperformed the industry in the past year. Yet, the company’s earnings surprise history is not that impressive. It surpassed the Zacks Consensus Estimate for earnings in only one of the trailing four quarters. We remain cautious of the elevated costs, which are likely to weigh on the financials. However, the company recorded a rise in average client trades per day in the fiscal third quarter with the trend continuing in the first month of the current quarter, indicating trading activity improvement. Further, its deal to acquire Scottrade is likely to be accretive to earnings per share (EPS) in double digits. Also, TD Ameritrade’s steady capital deployment activities are encouraging.”
Metro Wholesale & Food Specialist AG (ETR:B4B3) had its buy rating reaffirmed by analysts at DZ Bank AG.
Best Buy Co. (NYSE:BBY) had its buy rating reiterated by analysts at Loop Capital. They currently have a $72.00 target price on the stock.
Barclays PLC started coverage on shares of Baker Hughes A GE (NYSE:BHI). Barclays PLC issued a buy rating and a $41.00 price target on the stock.
Bemis (NYSE:BMS) had its hold rating reaffirmed by analysts at Citigroup Inc..
Citigroup Inc. started coverage on shares of Baozun (NASDAQ:BZUN). Citigroup Inc. issued a buy rating on the stock.
Commerce Bancshares (NASDAQ:CBSH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Shares of Commerce Bancshares have underperformed the industry in the past year. However, the company has surpassed the Zacks Consensus Estimate for earnings in three of the trailing four quarters. The company's efforts to expand its footprint in newer markets, an improving rate scenario and expectation of lesser regulations are expected to boost revenues further. Also, strong loan and deposit balance should support its profitability. Given a solid liquidity position, the company should be able to continue enhancing shareholder value through efficient capital deployment activities. However, rising expenses mainly due to increase in personnel costs and investments in franchise remain a major headwind. Further, a significant exposure to real estate loans remains a near-term concern for the company.”
Costco Wholesale Corporation (NASDAQ:COST) had its buy rating reaffirmed by analysts at UBS AG. They currently have a $190.00 target price on the stock.
Costco Wholesale Corporation (NASDAQ:COST) had its buy rating reiterated by analysts at Oppenheimer Holdings, Inc.. They currently have a $185.00 target price on the stock.
Costco Wholesale Corporation (NASDAQ:COST) had its buy rating reissued by analysts at Robert W. Baird. Robert W. Baird currently has a $200.00 price target on the stock.
Centrica PLC (OTC:CPYYY) was upgraded by analysts at Jefferies Group LLC from an underperform rating to a hold rating.
Carrefour SA (OTC:CRRFY) was downgraded by analysts at Jefferies Group LLC from a buy rating to a hold rating.
Carrefour SA (OTC:CRRFY) was downgraded by analysts at Natixis from a buy rating to a neutral rating.
Catalent (NASDAQ:CTLT) had its outperform rating reissued by analysts at Wells Fargo & Company. The firm currently has a $39.00 price target on the stock, up from their previous price target of $30.00.
Ctrip.com International (NASDAQ:CTRP) had its buy rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $62.00 price target on the stock.
Walt Disney Company (The) (NYSE:DIS) had its hold rating reissued by analysts at Loop Capital. They currently have a $106.00 price target on the stock, down from their previous price target of $107.00.
Enghouse Systems Limited (TSE:ENGH) was upgraded by analysts at Royal Bank Of Canada from a sector perform rating to an outperform rating. The firm currently has C$62.00 target price on the stock, down from their previous target price of C$64.00.
Expedia (NASDAQ:EXPE) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $173.00 price target on the stock.
Gilead Sciences (NASDAQ:GILD) had its buy rating reaffirmed by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $81.00 target price on the stock.
Gilead Sciences (NASDAQ:GILD) had its market perform rating reissued by analysts at Wells Fargo & Company. The firm currently has a $73.00 target price on the stock.
Gilead Sciences (NASDAQ:GILD) had its outperform rating reiterated by analysts at Cowen and Company. They currently have a $90.00 price target on the stock.
Home Depot, Inc. (The) (NYSE:HD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $168.00 target price on the stock. According to Zacks, “Home Depot’s spectacular past performance has helped it to surpass the industry in the past year. The company has been consistently gaining from its interconnected strategy, focus on Pro customers, and housing market recovery. These factors helped the company post a stellar second-quarter fiscal 2017 performance, which marked its highest ever quarterly sales and earnings. Notably, sales marked its 13th straight beat, while earnings retained its 5-year long trend of positive surprise. Results were driven by solid growth across all regions, both in stores and online. Also, Pro category sales continued to outperform, driven by constant efforts to enrich customers’ experiences. The sturdy first half and expectations of improved home prices encouraged the company to raise its fiscal 2017 view. However, gross margin remained plateaued, and is likely to fall 10 bps in fiscal 2017. Also, competition from online retailers may impact results.”
HeidelbergCement AG (OTC:HDELY) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating.
Incyte Corporation (NASDAQ:INCY) had its hold rating reiterated by analysts at Oppenheimer Holdings, Inc.. The firm currently has a $135.00 price target on the stock.
Incyte Corporation (NASDAQ:INCY) had its buy rating reissued by analysts at J P Morgan Chase & Co. J P Morgan Chase & Co currently has a $149.00 target price on the stock.
Lion Biotechnologies (NASDAQ:IOVA) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $16.00 price target on the stock.
BNP Paribas assumed coverage on shares of Julius Baer Gruppe (OTCMKTS:JBAXY). They issued an outperform rating on the stock.
Johnson & Johnson (NYSE:JNJ) had its top pick rating reaffirmed by analysts at UBS AG. The firm currently has a $148.00 price target on the stock.
Eli Lilly and (NYSE:LLY) had its hold rating reaffirmed by analysts at Leerink Swann.
Eli Lilly and (NYSE:LLY) had its buy rating reaffirmed by analysts at Piper Jaffray Companies. They currently have a $103.00 price target on the stock.
Methode Electronics (NYSE:MEI) had its buy rating reaffirmed by analysts at FBR & Co.
CIBC initiated coverage on shares of Mesoblast limited (NASDAQ:MESO). The firm issued an outperform rating and a $16.00 price target on the stock.
Marathon Petroleum Corporation (NYSE:MPC) had its buy rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $71.00 target price on the stock.
Maxim Integrated Products (NASDAQ:MXIM) had its buy rating reissued by analysts at Loop Capital. They currently have a $53.00 price target on the stock.
NN (NASDAQ:NNBR) had its market perform rating reiterated by analysts at William Blair.
National Oilwell Varco (NYSE:NOV) had its buy rating reaffirmed by analysts at FBR & Co. FBR & Co currently has a $42.00 price target on the stock.
Nutanix (NASDAQ:NTNX) had its buy rating reaffirmed by analysts at William Blair.
Nutanix (NASDAQ:NTNX) had its buy rating reissued by analysts at Bank of America Corporation. They currently have a $27.00 target price on the stock.
Palo Alto Networks (NYSE:PANW) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $155.00 price target on the stock.
Prima BioMed (NASDAQ:PBMD) had its buy rating reaffirmed by analysts at Maxim Group. They currently have a $7.00 target price on the stock.
Dave & Buster’s Entertainment (NASDAQ:PLAY) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $75.00 price target on the stock, down from their previous price target of $77.00.
Painted Pony Energy (TSE:PONY) was downgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a market perform rating. They currently have C$6.00 target price on the stock, down from their previous target price of C$7.00.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Restaurant Brands’ shares have widely outpaced its industry over the past year. Going forward, various sales-boosting initiatives like improving services, reimaging restaurants, menu innovation along with continued expansion should drive the top line. In fact, the company believes that there is opportunity to grow both the Tim Hortons and Burger King brands across the world. The acquisition of Popeye’s also bodes well as it adds a solid brand to its portfolio, which should further ramp up unit growth and aid in reducing costs. Moving ahead, the company aims to continue focusing on guest satisfaction and franchisee profitability, which it believes will drive long-term growth of brands. However, rising costs along with negative currency translation might dent the company’s profitability, while a soft consumer spending environment could keep comps under pressure.”
SolarEdge Technologies (NASDAQ:SEDG) had its sell rating reiterated by analysts at Axiom Securities.
Semtech Corporation (NASDAQ:SMTC) had its buy rating reiterated by analysts at Drexel Hamilton. They currently have a $45.00 target price on the stock.
South32 (OTC:SOUHY) was downgraded by analysts at Macquarie from an outperform rating to a neutral rating.
JMP Securities began coverage on shares of TCF Financial (AMEX:TCF). They issued a mkt perform rating on the stock.
Toronto Dominion Bank (The) (NYSE:TD) (TSE:TD) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $72.00 price target on the stock.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) had its neutral rating reiterated by analysts at Goldman Sachs Group Inc. The firm currently has a $21.00 target price on the stock, down from their previous target price of $28.00.
UBS AG (NYSE:UBS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “UBS Group AG’s shares have underperformed the industry in the last six months. UBS Group remains focused on building capital levels, global expansion and executing restructuring initiatives. Moreover, management anticipates achieving CHF 2.1 billion in net cost reductions by the end of 2017. Though, UBS Group AG’s profitability continues to be challenged by negative interest rates in the domestic economy and strict regulatory framework, its strong capital position remains a tailwind.”
Univar (NYSE:UNVR) had its hold rating reissued by analysts at Barclays PLC. They currently have a $32.00 target price on the stock.
Workday (NYSE:WDAY) had its buy rating reissued by analysts at Mitsubishi UFJ Financial Group. They currently have a $116.00 price target on the stock.
Workday (NYSE:WDAY) had its hold rating reissued by analysts at Deutsche Bank AG. The firm currently has a $105.00 price target on the stock, up from their previous price target of $95.00.
Yingli Green Energy Holding Company Limited (NYSE:YGE) had its sell rating reissued by analysts at Axiom Securities.
